Viking Therapeutics Inc (VKTX)

08:50 AM

If Viking Therapeutics Is Acquired, Here’s Who Wins - Yahoo Finance

08:50 AM

04:44 AM

Prediction: These 2 Obesity Drug Stocks Could Double in 2026 - AOL.com

04:44 AM

04:18 AM

Is Viking Therapeutics (VKTX) Pricing In Too Much Optimism After Recent Share Price Swings? - simplywall.st

04:18 AM

04:04 AM

Prediction: These 2 Obesity Drug Stocks Could Double in 2026 - The Motley Fool

04:04 AM

12:41 PM

Don't buy Viking Therapeutics stock until you read this - MSN

12:41 PM

May 25, 2026

Don't Buy Viking Therapeutics Stock Until You Read This - The Motley Fool

May 25, 2026

May 25, 2026

Could Viking Therapeutics Be the Next Eli Lilly? - AOL.com

May 25, 2026

May 25, 2026

A Look At Viking Therapeutics (VKTX) Valuation As Shares Show Mixed Recent Returns - Yahoo Finance

May 25, 2026

May 23, 2026

Is Viking Therapeutics a Top Takeover Target? - The Motley Fool

May 23, 2026

May 23, 2026

Should New Phase 2 Oral VK2735 Weight-Loss Data Require Action From Viking Therapeutics (VKTX) Investors? - simplywall.st

May 23, 2026

May 23, 2026

Viking Therapeutics, Inc. Stock 12‑Month Price Target Raised to $95.4, Implies 209% Upside - TradingView

May 23, 2026

May 22, 2026

Viking Therapeutics Analyst Ratings and Price Targets | NASDAQ:VKTX - Benzinga

May 22, 2026

May 22, 2026

2 Stocks That Could Realistically Double by 2030 - The Motley Fool

May 22, 2026

May 22, 2026

VKTX Technical Analysis | Trend, Signals & Chart Patterns | VIKING THERAPEUTICS INC (NASDAQ:VKTX) - ChartMill

May 22, 2026

May 21, 2026

Viking Therapeutics faces timeline risk, but upside could be huge - MSN

May 21, 2026

May 21, 2026

Viking Therapeutics to Participate at Upcoming Investor Conferences - StreetInsider

May 21, 2026

May 18, 2026

Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics' Pill Could Crash the Weight-Loss Party - The Globe and Mail

May 18, 2026

May 18, 2026

Three Biotechs That Are Top Takeover Targets - 24/7 Wall St.

May 18, 2026

May 18, 2026

Viking Therapeutics, Inc.Common Stock (NQ: VKTX - The Chronicle-Journal

May 18, 2026

May 17, 2026

VKTX stock slips premarket: A surprise weight loss drug beats Novo Nordisk in early animal tests - MSN

May 17, 2026

May 17, 2026

Viking Therapeutics, Inc. (VKTX) declines more than market: Some information for investors - MSN

May 17, 2026

May 17, 2026

The Bull Case For Viking Therapeutics (VKTX) Could Change Following New Oral VK2735 Obesity Data Release - Yahoo Finance

May 17, 2026

May 16, 2026

Avoiding Lag: Real-Time Signals in (VKTX) Movement - Stock Traders Daily

May 16, 2026

May 16, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 16, 2026

May 14, 2026

How New Oral VK2735 Obesity Data At Viking Therapeutics (VKTX) Has Changed Its Investment Story - simplywall.st

May 14, 2026

May 14, 2026

VKTX Q1 earnings miss on higher phase 3 development costs - MSN

May 14, 2026

May 13, 2026

Viking Therapeutics (VKTX) Valuation Revisited After New VK2735 Phase 2 Obesity Data Spurs Investor Interest - simplywall.st

May 13, 2026

May 12, 2026

Viking Therapeutics (VKTX) Reveals Promising Phase 2 Trial Resul - GuruFocus

May 12, 2026

May 12, 2026

Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTU - GuruFocus

May 12, 2026

May 12, 2026

Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026 - PR Newswire

May 12, 2026

May 12, 2026

Patients on experimental obesity drug lost up to 26.6 lb in 13 weeks - Stock Titan

May 12, 2026

May 11, 2026

Earnings call transcript: Viking Therapeutics Q1 2026 sees widened net loss - Investing.com India

May 11, 2026

May 11, 2026

Earnings call transcript: Viking Therapeutics Q1 2026 sees widened net loss By Investing.com - Investing.com South Africa

May 11, 2026